← Eichor
Study identifier: NCT07238023 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Promoting Active Living Among People With Metastatic Breast Cancer

Condition: Metastatic Invasive Breast Cancer  ·  Sponsor: University of Oklahoma

PhaseNA
Planned participants38
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

Individuals with metastatic breast cancer are living longer but often face persistent fatigue, functional decline, and psychological distress. Physical activity is generally safe for this population and may alleviate symptom burden. Yet, limited interventions are tailored to the unique and needs and preferences of this population. This study aims to evaluate the acceptability and feasibility of a mindfulness- and acceptance-based physical activity program designed to support mental, social, and spiritual well-being among people with metastatic breast cancer. A single group, pretest-posttest trial (N=38) will be conducted to inform scalable strategies to promote active living and enhance quality of life among people with advanced cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Michael C Robertson, PhD, MPH  ·  14052718001  ·  Michael-Robertson@ou.edu

Always discuss trial participation with your own doctor first.

Locations (1)

TSET Health Promotion Research CenterOklahoma City, Oklahoma, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07238023